| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.3M | — | -19.6% |
| SG&A Expense | $2.5M | — | +22.7% |
| Operating Income | -$4.8M | — | +2.1% |
| Net Income | -$5.9M | — | -15.3% |
| EPS (Basic) | -$0.20 | — | +87.4% |
| EPS (Diluted) | -$0.20 | — | +87.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $1.6M | -42.4% | -72.7% |
| Total Assets | $2.2M | -39.4% | -72.4% |
| Current Liabilities | $11.3M | +24.6% | +44.1% |
| Long-term Debt | $137K | — | — |
| Total Liabilities | $11.5M | +26.1% | +37.8% |
| Stockholders' Equity | -$9.3M | -70.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.8M | — | — |
| -2710.9% |